成功使用丹曲林钠治疗先天性肌强直（汤姆森病）患者。
Successful dantrolene sodium treatment of a patient with myotonia congenita (Thomsen's disease).
作者信息
Ohtaki E, Komori H, Yamaguchi Y, Matsuishi T
机构信息
Department of Pediatrics and Child Health, Kurume University School of Medicine, Japan.
出版信息
Acta Paediatr Jpn. 1991 Oct;33(5):668-71. doi: 10.1111/j.1442-200x.1991.tb01884.x.
Abstract
A 3 year, 10 month old male with myotonia congenita (Thomsen's disease) was placed on dantrolene sodium, which successfully abolished the myotonic phenomenon. Dantrolene sodium might therefore be a useful medicine for patients with Thomsen's disease who do not respond to other medicines, such as carbamazepine (CBZ), with a decrease in the myotonic phenomenon.
摘要
一名3岁10个月大的患有先天性肌强直（汤姆森病）的男性患者开始使用丹曲林钠治疗，该药成功消除了肌强直现象。因此，对于对卡马西平（CBZ）等其他药物无反应且肌强直现象有所减轻的汤姆森病患者，丹曲林钠可能是一种有效的药物。
Zotero 插件